Andrew Robson, Peter Saville, John Duthe, Simon Barnes Chief Sports Writer, Jon Ashworth, David Adams, Robert Cole, Colin Foster, Bruce H. Burniston, Andrew Pierce, Neelam Verjee, Laura Brady, Alexandra Frean, Neil Johnston, Kirsty McLeod, Peter Askew, Adam Sherwin Media Reporter, Greg Hurst Political Correspondent, Magnus Linklater, Peter Lansley, David Rhys Jones, Philip Howard, Eamonn Butler Director, David Chater, Suna Erdem, James Bone, Andrew Pierce and Michael Evans, Clive Davis, Alexandra Frean Social Affairs Correspondent, Thomas Edwards, Philip Warner, Richard Hobson One-Day Cricket Correspondent, Rosalind Renshaw, Carl Mortished, Sam Marlowe, Perikles F. Konstantinides, Sam Lister, Joe Joseph, Andrew Norfolk, Graham Schuil-Brewer, John Dunford, general secretary of the Secondary Heads Association, Valerie Elliott Countryside Editor, Stewart Tendler Crime Correspondent, Angus Nicol Piping Correspondent, Antonia Senior and Alison Gibson, Dominic Walsh, James Doran Wall Street Correspondent, Tom Bawden, Rick Poynor, Jill Dupleix, Tim Reid, Daniel Finkelstein, Angela Jameson Industrial Correspondent, Alan Hamilton, Stephen Farrell, Anthony Browne Brussels Correspondent, Val de Quetteville, Duncan Heenan, Phil Gordon, Richard Lloyd Parry, Lisa Armstrong Fashion Editor, Greg Hurst, Rachel Campbell Johnston, Caroline Merrell Banking Correspondent, Hugo Rifkind, Russell Kempson, Gary Duncan Economics Editor, Oliver Kay, Christine Selb, Jane Gordon, Alan Carpenter, Lisa Armstrong, Rick Broadbent, Patrick Hosking Investment Editor, Philip Webster and Valerie Elliott, Tom Baldwin, Mark Henderson Science Correspondent, Joyce Glasser, Ann Treneman, Karen Homer, Simon de Bruxelles, John Hopkins Golf Correspondent, Geoffrey Dean, Elaine Monaghan, Martin Samuel, Raymond Keene, Christine Buckley, Matt Dickinson, Christine Buckley Industrial Editor, Sean O'Neill, Chris Campling, Paul Miller, Richard Owen, Roger Boyes, Peter Dixon, Gabriel Rozenberg Economics Reporter, David H. Peart, David Hands Rugby Correspondent, Anna Frame, John Allison, Caroline Carter, Anne Ashworth, Joe Bolger Stock Markets, Philip Webster Political Editor, Tosin Sulaiman, Jane Pugh, Simon Johnson Director, Charles Pither (Medical Director), Martin McFall, Rick Reilly, Matthew Parris, Sally A. Stracey, George Caulkin, Russell Jenkins, Neil Fisher, Andrew Duncan, Bronwen Maddox Foreign Editor's, Michael Austin, Jan Snook, Peter Riddell, David Charter Chief Political Correspondent, Jack Malvern Arts Reporter, Simon Jenkins, Mark Henderson, Martin Waller, Chris Ayres, Gwilym Hughes, Alan Coren, Nigel Hawkes Health Editor, Sarah Butler, Ashling O'Connor, Oliver Kamm, Lydia Hislop, Clarence Barrett, Simon de Bruxelles and Steve Bird, Stephen Dalton, Bill Edgar, Richard Morrison, George Edwards, Alice Miles, Abigail Rayner, George Garside, Randy Cohen, Alan Lee Racing Correspondent, Alexandra Blair Education Correspondent, Owen Slot, Jan Raath, Jenny Davey, Peter Klinger, Patience Wheatcroft, Christopher Irvine, Frances Fyfield, Virginia Matthews,
... helped establish and develop the field of haematology Dennie Mancini All-rounder of British professional boxing who ... Do you agree with William Rees-Mogg that Gordon Brown's pensions policy has been one of ...
2004 - Gale Group | TDA
Clemens Krepler, Katrin Sproesser, Patricia Brafford, Marilda Beqiri, Bradley Garman, Min Xiao, Batool Shannan, Andrea Watters, Michela Perego, Gao Zhang, Adina Vultur, Xiangfan Yin, Qin Liu, Ioannis N. Anastopoulos, Bradley Wubbenhorst, Melissa Wilson, Wei Xu, Giorgos C. Karakousis, Michael D. Feldman, Xiaowei Xu, Ravi K. Amaravadi, Tara C. Gangadhar, David E. Elder, Lauren E. Haydu, Jennifer A. Wargo, Michael A. Davies, Yiling Lu, Gordon B. Mills, Dennie T. Frederick, Michal Barzily-Rokni, Keith T. Flaherty, Dave S.�B. Hoon, Michael J. Guarino, Joseph Bennett, R Ryan, Nicholas J. Petrelli, Carol L. Shields, Mizue Terai, Takami Sato, Andrew E. Aplin, Alexander Roesch, David B. Darr, Steven P. Angus, Rakesh Kumar, Ensar Halilovic, Giordano Caponigro, Sébastien Jeay, Jens Wuerthner, Annette O. Walter, Matthias Ocker, Matthew B. Boxer, Lynn M. Schuchter, Katherine L. Nathanson, Meenhard Herlyn,
Therapy of advanced melanoma is changing dramatically. Following mutational and biological subclassification of this heterogeneous cancer, several targeted and immune therapies were approved and increased survival significantly. To facilitate further advancements through pre-clinical in vivo modeling, we have established 459 patient-derived xenografts (PDX) and live tissue samples from 384 patients representing the full spectrum of clinical, therapeutic, mutational, and biological heterogeneity of ...
Tópico(s): Protein Degradation and Inhibitors
2017 - Cell Press | Cell Reports
Melvyn T. Chow, Aleksandra J. Ozga, Rachel L. Servis, Dennie T. Frederick, Jennifer A. Lo, David E. Fisher, Gordon J. Freeman, Genevieve M. Boland, Andrew D. Luster,
Despite compelling rates of durable clinical responses to programmed cell death-1 (PD-1) blockade, advances are needed to extend these benefits to resistant tumors. We found that tumor-bearing mice deficient in the chemokine receptor CXCR3 responded poorly to anti-PD-1 treatment. CXCR3 and its ligand CXCL9 were critical for a productive CD8+ T cell response in tumor-bearing mice treated with anti-PD-1 but were not required for the infiltration of CD8+ T cells into tumors. The anti-PD-1-induced anti- ...
Tópico(s): Immunotherapy and Immune Responses
2019 - Cell Press | Immunity
Ileabett M. Echevarría-Vargas, Patricia Reyes-Uribe, Adam N. Guterres, Xiangfan Yin, Andrew V. Kossenkov, Qin Liu, Gao Zhang, Clemens Krepler, Chaoran Cheng, Zhi Wei, Rajasekharan Somasundaram, Giorgos C. Karakousis, Wei Xu, Jennifer J.D. Morrissette, Yiling Lu, Gordon B. Mills, Ryan J. Sullivan, Benchun Miao, Dennie T. Frederick, Genevieve M. Boland, Keith T. Flaherty, Ashani T. Weeraratna, Meenhard Herlyn, Ravi K. Amaravadi, Lynn M. Schuchter, Christin E. Burd, Andrew E. Aplin, Xiaowei Xu, Jessie Villanueva,
... Wei Xu3, Jennifer JD Morrissette5,6, Yiling Lu7, Gordon B Mills7, Ryan J Sullivan8, Miao Benchun8, Dennie T Frederick8, Genevieve Boland9, Keith T Flaherty8, Ashani ...
Tópico(s): CAR-T cell therapy research
2018 - Springer Nature | EMBO Molecular Medicine
... episode miniseries. Directed by John Erick Dowdle and Dennie Gordon. The Paramount Network, 2018. Spencer Dew, Spencer Dew ...
Tópico(s): Cinema and Media Studies
2018 - Wiley | Religious Studies Review
Charles Marusak, Varsha Thakur, Yuan Li, Juliano T. Freitas, Patrick M. Zmina, Vijay S. Thakur, Mayland Chang, Ming Gao, Jiufeng Tan, Min Xiao, Yiling Lu, Gordon B. Mills, Keith T. Flaherty, Dennie T. Frederick, Benchun Miao, Ryan J. Sullivan, Tabea Moll, Genevieve M. Boland, Meenhard Herlyn, Gao Zhang, Barbara Bedogni,
Abstract Purpose: The extracellular matrix (ECM) is an intriguing, yet understudied component of therapy resistance. Here, we investigated the role of ECM remodeling by the collagenase, MT1-MMP, in conferring resistance of v-Raf murine sarcoma viral oncogene homolog B1 (BRAF)-mutant melanoma to BRAF inhibitor (BRAFi) therapy. Experimental Design: Publicly available RNA-sequencing data and reverse phase protein array were used to determine the relevance of MT1-MMP upregulation in BRAFi-resistant melanoma ...
Tópico(s): Protease and Inhibitor Mechanisms
2020 - American Association for Cancer Research | Clinical Cancer Research
Zachary A. Cooper, Vikram R. Juneja, Peter T. Sage, Dennie T. Frederick, Adriano Piris, Devarati Mitra, Jennifer A. Lo, F. Stephen Hodi, Gordon J. Freeman, Marcus Bosenberg, Martin McMahon, Keith T. Flaherty, David E. Fisher, Arlene H. Sharpe, Jennifer A. Wargo,
BRAF-targeted therapy results in objective responses in the majority of patients; however, the responses are short lived (∼6 months). In contrast, treatment with immune checkpoint inhibitors results in a lower response rate, but the responses tend to be more durable. BRAF inhibition results in a more favorable tumor microenvironment in patients, with an increase in CD8(+) T-cell infiltrate and a decrease in immunosuppressive cytokines. There is also increased expression of the immunomodulatory molecule ...
Tópico(s): CAR-T cell therapy research
2014 - American Association for Cancer Research | Cancer Immunology Research
Lei Guan, Bin Wu, Ting Li, Lynn A. Beer, Gaurav Sharma, Mingyue Li, Chin Nien Lee, Shujing Liu, Changsong Yang, Lili Huang, Dennie T. Frederick, Genevieve M. Boland, Guang-Can Shao, Tatyana Svitkina, Kathy Q. Cai, Fangping Chen, Meng‐Qiu Dong, Gordon B. Mills, Lynn M. Schuchter, Giorgos C. Karakousis, Tara C. Mitchell, Keith T. Flaherty, David W. Speicher, Youhai H. Chen, Meenhard Herlyn, Ravi K. Amaravadi, Xiaowei Xu, Wei Guo,
The lack of tumor infiltration by CD8+ T cells is associated with poor patient response to anti-PD-1 therapy. Understanding how tumor infiltration is regulated is key to improving treatment efficacy. Here, we report that phosphorylation of HRS, a pivotal component of the ESCRT complex involved in exosome biogenesis, restricts tumor infiltration of cytolytic CD8+ T cells. Following ERK-mediated phosphorylation, HRS interacts with and mediates the selective loading of PD-L1 to exosomes, which inhibits ...
Tópico(s): Cancer Immunotherapy and Biomarkers
2022 - Nature Portfolio | Nature Communications
Lawrence N. Kwong, Genevieve M. Boland, Dennie T. Frederick, Timothy L. Helms, Ahmad T. Akid, John P. Miller, Shan Jiang, Zachary A. Cooper, Xingzhi Song, Sahil Seth, Jennifer Kamara, Alexei Protopopov, Gordon B. Mills, Keith T. Flaherty, Jennifer A. Wargo, Lynda Chin,
Multiple mechanisms have been described that confer BRAF inhibitor resistance to melanomas, yet the basis of this resistance remains undefined in a sizable portion of patient samples. Here, we characterized samples from a set of patients with melanoma that included individuals at baseline diagnosis, on BRAF inhibitor treatment, and with resistant tumors at both the protein and RNA levels. Using RNA and DNA sequencing, we identified known resistance-conferring mutations in 50% (6 of 12) of the resistant ...
Tópico(s): HER2/EGFR in Cancer Research
2015 - American Society for Clinical Investigation | Journal of Clinical Investigation
Y.N. Vashisht Gopal, Helen Rizos, Guo Chen, Wanleng Deng, Dennie T. Frederick, Zachary A. Cooper, Richard A. Scolyer, Gulietta M. Pupo, Kakajan Komurov, Vasudha Sehgal, Jiexin Zhang, Lalit R. Patel, Cristiano Gonçalves Pereira, Bradley M. Broom, Gordon B. Mills, Prahlad T. Ram, Paul D. Smith, Jennifer A. Wargo, Georgina V. Long, Michael A. Davies,
Metabolic heterogeneity is a key factor in cancer pathogenesis. We found that a subset of BRAF- and NRAS-mutant human melanomas resistant to the MEK inhibitor selumetinib displayed increased oxidative phosphorylation (OxPhos) mediated by the transcriptional coactivator PGC1α. Notably, all selumetinib-resistant cells with elevated OxPhos could be resensitized by cotreatment with the mTORC1/2 inhibitor AZD8055, whereas this combination was ineffective in resistant cell lines with low OxPhos. In both ...
Tópico(s): Protein Kinase Regulation and GTPase Signaling
2014 - American Association for Cancer Research | Cancer Research
Gao Zhang, Lawrence W. Wu, Ilgen Mender, Michal Barzily-Rokni, Marc R. Hammond, Omotayo Ope, Chaoran Cheng, Themistoklis Vasilopoulos, Sergio Randell, Norah Sadek, Aurelie Beroard, Min Xiao, Tian Tian, Jiufeng Tan, Umar Saeed, Eric Sugarman, Clemens Krepler, Patricia Brafford, Katrin Sproesser, Sengottuvelan Murugan, Rajasekharan Somasundaram, Bradley Garman, Bradley Wubbenhorst, Jonathan Woo, Xiangfan Yin, Qin Liu, Dennie T. Frederick, Benchun Miao, Wei Xu, Giorgos C. Karakousis, Xiaowei Xu, Lynn M. Schuchter, Tara C. Mitchell, Lawrence N. Kwong, Ravi K. Amaravadi, Yiling Lu, Genevieve M. Boland, Zhi Wei, Katherine L. Nathanson, Utz Herbig, Gordon B. Mills, Keith T. Flaherty, Meenhard Herlyn, Jerry W. Shay,
Purpose: Telomerase promoter mutations are highly prevalent in human tumors including melanoma. A subset of patients with metastatic melanoma often fail multiple therapies, and there is an unmet and urgent need to prolong disease control for those patients.Experimental Design: Numerous preclinical therapy-resistant models of human and mouse melanoma were used to test the efficacy of a telomerase-directed nucleoside, 6-thio-2'-deoxyguanosine (6-thio-dG). Integrated transcriptomics and proteomics approaches ...
Tópico(s): Cancer Cells and Metastasis
2018 - American Association for Cancer Research | Clinical Cancer Research
Bart Geboers, Dennie Meijer, William Counter, Alexandar Blazevski, James Thompson, Paul Doan, William Gondoputro, Athos Katelaris, Anne‐Maree Haynes, Warick Delprado, Gordon O’Neill, Carlo Yuen, André N. Vis, Pim J van Leeuwen, Bao Ho, Victor Liu, Jonathan Lee, Maarten L. Donswijk, Daniela E. Oprea‐Lager, Matthijs J. Scheltema, Louise Emmett, Phillip D. Stricker,
To evaluate the additional value of prostate-specific membrane antigen positron emission tomography (PSMA-PET) to conventional diagnostic tools to select patients for hemi-ablative focal therapy (FT).
Tópico(s): Radiomics and Machine Learning in Medical Imaging
2023 - Wiley | BJU International
Jianglan Liu, Vito W. Rebecca, Andrew V. Kossenkov, Thomas Connelly, Qin Liu, Alexis Gutierrez, Min Xiao, Ling Li, Gao Zhang, Anastasia Samarkina, Delaine Zayasbazan, Jie Zhang, Chaoran Cheng, Zhi Wei, Gretchen M. Alicea, Mizuho Fukunaga‐Kalabis, Clemens Krepler, Pedro Aza‐Blanc, Chih-Cheng Yang, Bela Delvadia, Cynthia Tong, Ye Huang, Maya Delvadia, Alice S. Morias, Katrin Sproesser, Patricia Brafford, Joshua X. Wang, Marilda Beqiri, Rajasekharan Somasundaram, Adina Vultur, Denitsa M. Hristova, Lawrence W. Wu, Yiling Lu, Gordon B. Mills, Wei Xu, Giorgos C. Karakousis, Xiaowei Xu, Lynn M. Schuchter, Tara C. Mitchell, Ravi K. Amaravadi, Lawrence N. Kwong, Dennie T. Frederick, Genevieve M. Boland, Joseph M. Salvino, David W. Speicher, Keith T. Flaherty, Ze’ev A. Ronai, Meenhard Herlyn,
Abstract Metastatic melanoma is challenging to clinically address. Although standard-of-care targeted therapy has high response rates in patients with BRAF-mutant melanoma, therapy relapse occurs in most cases. Intrinsically resistant melanoma cells drive therapy resistance and display molecular and biologic properties akin to neural crest-like stem cells (NCLSC) including high invasiveness, plasticity, and self-renewal capacity. The shared transcriptional programs and vulnerabilities between NCLSCs ...
Tópico(s): Protein Degradation and Inhibitors
2021 - American Association for Cancer Research | Cancer Research
Lawrence N. Kwong, Genevieve M. Boland, Dennie T. Frederick, Timothy L. Helms, John P. Miller, Shan Jiang, Zachary A. Cooper, Alexei Protopopov, Gordon B. Mills, Keith T. Flaherty, Jennifer A. Wargo, Lynda Chin,
... timeframe. Citation Format: Lawrence N. Kwong, Genevieve Boland, Dennie T. Frederick, Timothy Helms, John P. Miller, Shan Jiang, Zachary A. Cooper, Alexei Protopopov, Gordon B. Mills, Keith Flaherty, Jennifer A. Wargo, Lynda ...
Tópico(s): Computational Drug Discovery Methods
2015 - American Association for Cancer Research | Clinical Cancer Research
Lawrence N. Kwong, Genevieve M. Boland, Dennie T. Frederick, Timothy L. Helms, Ahmad T. Akid, John Miller, Shan Jiang, Zachary A. Cooper, Xingzhi Song, Sahil Seth, Jennifer Kamara, Alexei Protopopov, Gordon B. Mills, Keith T. Flaherty, Jennifer A. Wargo, Lynda Chin,
... alteration. Citation Format: Lawrence N. Kwong, Genevieve Boland, Dennie Frederick, Timothy Helms, Ahmad Akid, John Miller, Shan Jiang, Zachary Cooper, Xingzhi Song, Sahil Seth, Jennifer Kamara, Alexei Protopopov, Gordon Mills, Keith Flaherty, Jennifer Wargo, Lynda Chin. A ...
Tópico(s): Computational Drug Discovery Methods
2015 - American Association for Cancer Research | Cancer Research
... Results of Early Discharge in 506 Outpatients1Carole J. Dennie, , Frederick R. Matzinger, , J. Robert Marriner, , and Donna ...
Tópico(s): Head and Neck Cancer Studies
1998 - Radiological Society of North America | Radiology
Gao Zhang, Dennie T. Frederick, Lawrence W. Wu, Zhi Wei, Clemens Krepler, Satish Srinivasan, Young Chan Chae, Xiaowei Xu, Harry Choi, Elaida Dimwamwa, Omotayo Ope, Batool Shannan, Devraj Basu, Dongmei Zhang, Manti Guha, Min Xiao, Sergio Randell, Katrin Sproesser, Wei Xu, Jephrey Liu, Giorgos C. Karakousis, Lynn M. Schuchter, Tara C. Gangadhar, Ravi K. Amaravadi, Mengnan Gu, Caiyue Xu, Abheek Ghosh, Weiting Xu, Tian Tian, Jie Zhang, Shijie Zha, Qin Liu, Patricia Brafford, Ashani T. Weeraratna, Michael A. Davies, Jennifer A. Wargo, Narayan G. Avadhani, Yiling Lu, Gordon B. Mills, Dario C. Altieri, Keith T. Flaherty, Meenhard Herlyn,
Targeting multiple components of the MAPK pathway can prolong the survival of patients with BRAFV600E melanoma. This approach is not curative, as some BRAF-mutated melanoma cells are intrinsically resistant to MAPK inhibitors (MAPKi). At the systemic level, our knowledge of how signaling pathways underlie drug resistance needs to be further expanded. Here, we have shown that intrinsically resistant BRAF-mutated melanoma cells with a low basal level of mitochondrial biogenesis depend on this process ...
Tópico(s): Heat shock proteins research
2016 - American Society for Clinical Investigation | Journal of Clinical Investigation
Hezhe Lu, Shujing Liu, Gao Zhang, Bin Wu, Yueyao Zhu, Dennie T. Frederick, Yi Hu, Wenqun Zhong, Sergio Randell, Norah Sadek, Wei Zhang, Gang Chen, Chaoran Cheng, Jingwen Zeng, Lawrence W. Wu, Jie Zhang, Xiaoming Liu, Wei Xu, Clemens Krepler, Katrin Sproesser, Min Xiao, Benchun Miao, Jianglan Liu, Claire Song, Jephrey Y. Liu, Giorgos C. Karakousis, Lynn M. Schuchter, Yiling Lu, Gordon B. Mills, Yu‐Sheng Cong, Jonathan Chernoff, Jun Guo, Genevieve M. Boland, Ryan J. Sullivan, Zhi Wei, Jeffrey Field, Ravi K. Amaravadi, Keith T. Flaherty, Meenhard Herlyn, Xiaowei Xu, Wei Guo,
BRAF-inhibition resistance in metastatic melanoma occurs through p21-activated kinase-mediated reactivation of ERK, whereas resistance to combined BRAF and MEK inhibition occurs through p21-activated kinase-mediated regulation of JNK and β-catenin phosphorylation, mTOR pathway activation and apoptosis inhibition in many patients. Melanomas have been shown to respond well to the inhibition of BRAF and MEK signalling, but in many cases the tumours become resistant. Multiple resistance mechanisms have ...
Tópico(s): Cellular Mechanics and Interactions
2017 - Nature Portfolio | Nature
Jennifer A. Lo, Masayoshi Kawakubo, Vikram R. Juneja, Mack Y. Su, Tal Hadad Erlich, Martin W. LaFleur, Lajos V. Kemény, Mamunur Rashid, Mohsen Malehmir, S. Alireza Rabi, Rumya Raghavan, Jennifer Allouche, Gyulnara G. Kasumova, Dennie T. Frederick, Kristen E. Pauken, Qing Yu Weng, Marcelo Pereira da Silva, Yu Xu, Anita A. J. van der Sande, Whitney Silkworth, Elisabeth Roider, Edward P. Browne, David Lieb, Belinda Wang, Levi A. Garraway, Catherine J. Wu, Keith T. Flaherty, Constance Brinckerhoff, David W. Mullins, David J. Adams, Nir Hacohen, Mai P. Hoang, Genevieve M. Boland, Gordon J. Freeman, Arlene H. Sharpe, Dieter Manstein, David E. Fisher,
Although immune checkpoint inhibitors (ICIs), such as anti-programmed cell death protein-1 (PD-1), can deliver durable antitumor effects, most patients with cancer fail to respond. Recent studies suggest that ICI efficacy correlates with a higher load of tumor-specific neoantigens and development of vitiligo in patients with melanoma. Here, we report that patients with low melanoma neoantigen burdens who responded to ICI had tumors with higher expression of pigmentation-related genes. Moreover, expansion ...
Tópico(s): Immune Cell Function and Interaction
2021 - American Association for the Advancement of Science | Science Translational Medicine
... Charlwood, 'Unions', 61–75. 8. See, for example, Gordon, New Deals; Martin, Stuck in Neutral; Swenson, Capitalists; ...
Tópico(s): Employment and Welfare Studies
2011 - Taylor & Francis | Labor History
... by Norval Morris. In Place of Prison by Dennie Briggs. Boards of Visitors of Penal Institutions by Earl Jellicoe Social Work in the Environment by Martin Davies IMPACT: Intensive Matched Probation and After‐Care Treatment (Vol. 1) by M.S. Counselling and School Social Work by Gordon Rose and Terry F. Marshall. Varieties of Residential ...
1976 - Wiley | The Howard Journal of Criminal Justice
Hezhe Lu, Shujing Liu, Gao Zhang, Bin Wu, Yueyao Zhu, Dennie T. Frederick, Yi Hu, Wenqun Zhong, Sergio Randell, Norah Sadek, Wei Zhang, Gang Chen, Chaoran Cheng, Jingwen Zeng, Lawrence W. Wu, Jie Zhang, Xiaoming Liu, Wei Xu, Clemens Krepler, Katrin Sproesser, Min Xiao, Benchun Miao, Jianglan Liu, Claire Song, Jephrey Y. Liu, Giorgos C. Karakousis, Lynn M. Schuchter, Yiling Lu, Gordon B. Mills, Yu‐Sheng Cong, Jonathan Chernoff, Jun Guo, Genevieve M. Boland, Ryan J. Sullivan, Zhi Wei, Jeffrey Field, Ravi K. Amaravadi, Keith T. Flaherty, Meenhard Herlyn, Xiaowei Xu, Wei Guo,
In this Letter, two relevant references were omitted; see the accompanying Amendment for details. The original Letter has not been corrected.
Tópico(s): Cancer Mechanisms and Therapy
2018 - Nature Portfolio | Nature